Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
PUT
Teva Pharmaceuticals
TEVA
$44.4B
| $8.52M | ﹤0.01% |
1,131,400
+714,200
| +171% | +$5.79M |
|
2127
PUT
Capital One
COF
$132B
| $8.51M | ﹤0.01% |
77,800
-12,200
| -14% | -$1.22M |
|
2128
PUT
Agilent Technologies
A
$44.2B
| $8.5M | ﹤0.01% |
70,700
+2,300
| +3% | +$293K |
|
2129
PUT
Phillips 66
PSX
$96.3B
| $8.5M | ﹤0.01% |
89,100
+21,800
| +32% | +$2.12M |
|
2130
Herc Holdings
HRI
$5.2B
| $8.48M | ﹤0.01% |
61,971
-110,563
| -64% | -$12.2M |
|
2131
Blue Owl Capital
OWL
$8.25B
| $8.48M | ﹤0.01% |
727,502
-1,742,178
| -71% | -$18.8M |
|
2132
Alamo Group
ALG
$1.99B
| $8.47M | ﹤0.01% |
46,067
+31,742
| +222% | +$5.66M |
|
|
KNSW
2133
DELISTED
KnightSwan Acquisition Corporation
KNSW
| $8.46M | ﹤0.01% |
800,000
| – | – |
|
2134
PUT
US Foods
USFD
$23.3B
| $8.43M | ﹤0.01% |
+191,700
| New | +$7.61M |
|
2135
Seres Therapeutics
MCRB
$49.2M
| $8.43M | ﹤0.01% |
87,996
+67,572
| +331% | +$7.35M |
|
2136
SunCoke Energy
SXC
$860M
| $8.43M | ﹤0.01% |
1,070,626
+978,145
| +1,058% | +$7.68M |
|
2137
DXP Enterprises
DXPE
$3B
| $8.42M | ﹤0.01% |
231,343
+155,344
| +204% | +$4.69M |
|
2138
PUT
State Street SPDR S&P Metals & Mining ETF
XME
$4.9B
| $8.42M | ﹤0.01% |
165,700
+161,200
| +3,582% | +$7.92M |
|
2139
Qualys
QLYS
$6.53B
| $8.41M | ﹤0.01% |
65,138
+49,885
| +327% | +$6.14M |
|
2140
Warrior Met Coal
HCC
$5.74B
| $8.41M | ﹤0.01% |
215,916
+75,986
| +54% | +$2.75M |
|
|
SEMR
2141
DELISTED
Semrush
SEMR
| $8.4M | ﹤0.01% |
878,252
+609,405
| +227% | +$5.39M |
|
|
APLS
2142
CALL
DELISTED
Apellis Pharmaceuticals
APLS
| $8.4M | ﹤0.01% |
92,200
+62,200
| +207% | +$5.37M |
|
|
FYBR
2143
PUT
DELISTED
Frontier Communications
FYBR
| $8.38M | ﹤0.01% |
449,600
-187,500
| -29% | -$3.52M |
|
2144
Nokia
NOK
$59.1B
| $8.37M | ﹤0.01% |
2,010,904
-21,564,456
| -91% | -$91.2M |
|
2145
PNC Financial Services
PNC
$96.9B
| $8.36M | ﹤0.01% |
66,413
-75,763
| -53% | -$9.26M |
|
2146
Sterling Infrastructure
STRL
$15.4B
| $8.35M | ﹤0.01% |
149,586
+143,749
| +2,463% | +$6.37M |
|
|
CADE
2147
DELISTED
Cadence Bank
CADE
| $8.35M | ﹤0.01% |
424,944
-641,162
| -60% | -$12.6M |
|
|
LGTY
2148
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $8.34M | ﹤0.01% |
793,301
+114,422
| +17% | +$1.38M |
|
2149
CALL
Halliburton
HAL
$29.8B
| $8.34M | ﹤0.01% |
252,700
-101,400
| -29% | -$3.2M |
|
2150
Expro Ltd
XPRO
$2.02B
| $8.33M | ﹤0.01% |
470,314
-111,226
| -19% | -$2.01M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.